109 related articles for article (PubMed ID: 38639057)
21. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
Front Endocrinol (Lausanne); 2021; 12():646793. PubMed ID: 34122331
[TBL] [Abstract][Full Text] [Related]
22. Identification of TRPM2 as a Potential Therapeutic Target Associated with Immune Infiltration: A Comprehensive Pan-Cancer Analysis and Experimental Verification in Ovarian Cancer.
Zheng D; Long S; Xi M
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569287
[TBL] [Abstract][Full Text] [Related]
23. Two lineages of immune cells that differentially express the vitamin D receptor.
Cantorna MT; Arora J
J Steroid Biochem Mol Biol; 2023 Apr; 228():106253. PubMed ID: 36657728
[TBL] [Abstract][Full Text] [Related]
24. In silico analysis reveals PRDX4 as a prognostic and oncogenic marker in renal papillary cell carcinoma.
Kocatürk B
Gene; 2023 Apr; 859():147201. PubMed ID: 36646187
[TBL] [Abstract][Full Text] [Related]
25. Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer.
Luo L; Wang Z; Hu T; Feng Z; Zeng Q; Shu X; Wu A; Huang P; Cao Y; Tu Y; Li Z
Biosci Rep; 2023 Jan; 43(1):. PubMed ID: 36545914
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D deficiency aggravates growth and metastasis of prostate cancer through promoting EMT in two β-catenin-related mechanisms.
Zhang ZH; Liu MD; Yao K; Xu S; Yu DX; Xie DD; Xu DX
J Nutr Biochem; 2023 Jan; 111():109177. PubMed ID: 36223833
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
Zhang Y; Wang H; Liu Y; Yang J; Zuo X; Dong M; Zhang Z; Shi Y; Deng X; Lv Y
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36094557
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Detection of the Presence of Vitamin D Receptor in Childhood Solid Tumors.
Juhász O; Jákob N; Rajnai H; Imrei M; Garami M
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884356
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer.
Kim MJ; Kim D; Koo JS; Lee JH; Nam KH
Technol Cancer Res Treat; 2022; 21():15330338221089933. PubMed ID: 35379049
[No Abstract] [Full Text] [Related]
30. C/EBPβ mediates anti-proliferative effects of 1,25(OH)2D on differentiated thyroid carcinoma cells.
Xu F; Ling Y; Yuan J; Zeng Q; Li L; Dai D; Xia X; Sun R; Zhang R; Xie Z
Endocr Relat Cancer; 2022 May; 29(6):321-334. PubMed ID: 35343920
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors.
Bueno AC; Stecchini MF; Marrero-Gutiérrez J; More CB; Leal LF; Gomes DC; de Lima Neto DF; Brandalise SR; Cardinalli IA; Yunes JA; Junqueira T; Scrideli CA; Molina CAF; Ramalho FS; Tucci S; Coeli-Lacchini FB; Moreira AC; Ramalho L; Vêncio RZN; De Castro M; Antonini SRR
Eur J Endocrinol; 2022 Apr; 186(5):573-585. PubMed ID: 35290212
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment.
Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C
Front Oncol; 2022; 12():724261. PubMed ID: 35237505
[TBL] [Abstract][Full Text] [Related]
33. The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer.
Chan RH; Chen PC; Yeh YM; Lin BW; Yang KD; Shen MR; Lin PC
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204406
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.
Ladumor Y; Seong BKA; Hallett R; Valencia-Sama I; Adderley T; Wang Y; Kee L; Gont A; Kaplan DR; Irwin MS
Mol Cancer Res; 2022 Jun; 20(6):895-908. PubMed ID: 35190818
[TBL] [Abstract][Full Text] [Related]
35. Effect of immunotherapy on the immune microenvironment in advanced recurrent cervical cancer.
Chen R; Yang W; Li Y; Cheng X; Nie Y; Liu D; Wang H
Int Immunopharmacol; 2022 May; 106():108630. PubMed ID: 35189471
[TBL] [Abstract][Full Text] [Related]
36. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D receptor regulates proliferation and differentiation of thyroid carcinoma via the E-cadherin-β-catenin complex.
Ling Y; Xu F; Xia X; Dai D; Sun R; Xie Z
J Mol Endocrinol; 2022 Mar; 68(3):137-151. PubMed ID: 35099410
[TBL] [Abstract][Full Text] [Related]
38. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
39. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk.
Zhou A; Selvanayagam JB; Hyppönen E
Eur Heart J; 2022 May; 43(18):1731-1739. PubMed ID: 34891159
[TBL] [Abstract][Full Text] [Related]
40. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
